Literature DB >> 19846966

S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma.

Yasuhiro Ito1, Kazumori Arai, Ryushi Nozawa, Hiroshi Yoshida, Mitsuyoshi Hirokawa, Mitsuhiro Fukushima, Hiroyuki Inoue, Chisato Tomoda, Minoru Kihara, Takuya Higashiyama, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Akira Miyauchi.   

Abstract

BACKGROUND: S100A8 plays a role in various functions of myeloid cells by forming a heterocomplex with S100A9. S100A8 and S100A9 are also known to be overexpressed in certain species of carcinomas.
MATERIALS AND METHODS: In this study, the protein expression of S100A8 as well as that of S100A9 was investigated in thyroid tumors.
RESULTS: All of the undifferentiated carcinomas were immunopositive for S100A8 and S100A9 and overlap between staining patterns of both proteins was observed. In poorly differentiated carcinomas, all the cases were negative for S100A8, while slight immunopositivity of S100A9 was seen in 2 cases. Papillary carcinoma, follicular carcinoma, follicular adenoma and medullary carcinoma and normal follicules were negative for both proteins.
CONCLUSION: S100A8 plays an important role in dedifferentiation of thyroid carcinoma possibly by forming a complex with S100A9.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846966

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.

Authors:  Prokopios P Argyris; Zachary Slama; Chris Malz; Ioannis G Koutlas; Betty Pakzad; Ketan Patel; Deepak Kademani; Ali Khammanivong; Mark C Herzberg
Journal:  Oral Oncol       Date:  2019-06-04       Impact factor: 5.337

Review 2.  Calprotectin and the Initiation and Progression of Head and Neck Cancer.

Authors:  P P Argyris; Z M Slama; K F Ross; A Khammanivong; M C Herzberg
Journal:  J Dent Res       Date:  2018-02-14       Impact factor: 6.116

3.  S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.

Authors:  Ashley N Reeb; Wen Li; Will Sewell; Laura A Marlow; Han W Tun; Robert C Smallridge; John A Copland; Kyle Spradling; Rebecca Chernock; Reigh-Yi Lin
Journal:  J Clin Endocrinol Metab       Date:  2014-11-25       Impact factor: 5.958

Review 4.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

5.  S100A8 and S100A9 Positive Cells in Colorectal Carcinoma: Clinicopathological Analysis.

Authors:  Cumhur İbrahim Başsorgun; Betül Unal; Nuray Erin; Anıl Ozlük; Ozlem Ceren Uzun; Gülsüm Özlem Elpek
Journal:  Gastroenterol Res Pract       Date:  2014-10-13       Impact factor: 2.260

6.  Potential Role of S100A8 in Cutaneous Squamous Cell Carcinoma Differentiation.

Authors:  Jung-Min Shin; In-Kyu Chang; Young-Ho Lee; Min-Kyung Yeo; Jin-Man Kim; Kyung-Cheol Sohn; Myung Im; Young-Joon Seo; Chang-Deok Kim; Jeung-Hoon Lee; Young Lee
Journal:  Ann Dermatol       Date:  2016-03-31       Impact factor: 1.444

7.  Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer.

Authors:  Biao Fan; Lian-Hai Zhang; Yong-Ning Jia; Xi-Yao Zhong; Yi-Qiang Liu; Xiao-Jing Cheng; Xiao-Hong Wang; Xiao-Fang Xing; Ying Hu; Ying-Ai Li; Hong Du; Wei Zhao; Zhao-Jian Niu; Ai-Ping Lu; Ji-You Li; Jia-Fu Ji
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

8.  S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.

Authors:  Liang Duan; Rui Wu; Liwei Ye; Haiyan Wang; Xia Yang; Yunyuan Zhang; Xian Chen; Guowei Zuo; Yan Zhang; Yaguang Weng; Jinyong Luo; Min Tang; Qiong Shi; Tongchuan He; Lan Zhou
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

9.  S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.

Authors:  Ali Khammanivong; Chengxing Wang; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Gene expression signature in mouse thyroid tissue after (131)I and (211)At exposure.

Authors:  Nils Rudqvist; Johan Spetz; Emil Schüler; Britta Langen; Toshima Z Parris; Khalil Helou; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2015-10-22       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.